Related Experiment Video

Updated: Jul 19, 2026

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
09:26

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

Antibiotic resistance in respiratory pathogens

M A Dominguez1, R Pallares

  • 1Microbiology Service and Infectious Disease Service, Hospital Bellvitge and University of Barcelona, L'Hospitalet, Barcelona, Spain.

Current Opinion in Infectious Diseases
|October 13, 2006
PubMed

Insights

Antimicrobial resistance in respiratory pathogens like pneumococci, Moraxella catarrhalis, and Haemophilus influenzae is a growing global problem. This widespread resistance, including to penicillin and ampicillin, presents significant therapeutic challenges, especially with drug-resistant tuberculosis.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Increasing antibiotic resistance in key respiratory pathogens is a significant global health concern.
  • Prevalence of resistance to penicillin and multiple antimicrobial agents in pneumococci is rising.
  • Ampicillin resistance in Moraxella catarrhalis and Haemophilus influenzae, due to betalactamase production, is widespread.

Purpose of the Study:

  • To highlight the escalating issue of antibiotic resistance in common respiratory pathogens.
  • To underscore the therapeutic challenges posed by multidrug-resistant strains.
  • To emphasize the global prevalence of these resistance patterns.

Main Methods:

  • Review of recent epidemiological data on antimicrobial resistance patterns.
  • Analysis of resistance mechanisms, including betalactamase production.
  • Assessment of the clinical impact of resistance in respiratory tract infections.

Main Results:

  • Dramatic increase in antibiotic resistance observed in pneumococci, Moraxella catarrhalis, and Haemophilus influenzae.
  • High prevalence of penicillin and multi-drug resistance in pneumococci globally.
  • Widespread ampicillin resistance in Moraxella catarrhalis and Haemophilus influenzae linked to betalactamase production.
  • Emergence of multidrug-resistant tuberculosis as a critical therapeutic challenge.

Conclusions:

  • Urgent need for strategies to combat rising antibiotic resistance in respiratory pathogens.
  • Multidrug resistance poses a significant threat to effective treatment of respiratory infections.
  • Global surveillance and development of new antimicrobial agents are crucial.

More Related Videos

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes08:58

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes

Published on: March 3, 2023

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...